Belluscura (LSE:BELL) Inventories, Finished Goods: £1.21 Mil (As of Jun. 2024)


What is Belluscura Inventories, Finished Goods?

Belluscura LSE:BELL Inventories, Finished Goods is £1.21 Mil as of Jun. 2024.

Belluscura's quarterly finished goods increased from Jun. 2023 (£0.00 Mil) to Dec. 2023 (£1.13 Mil) and increased from Dec. 2023 (£1.13 Mil) to Jun. 2024 (£1.21 Mil).

Belluscura's annual finished goods increased from Dec. 2021 (£0.00 Mil) to Dec. 2022 (£1.43 Mil) but then declined from Dec. 2022 (£1.43 Mil) to Dec. 2023 (£1.13 Mil).

Belluscura Inventories, Finished Goods Historical Data

* Premium members only.

The historical data trend for Belluscura's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Belluscura Inventories, Finished Goods Chart

Belluscura Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Inventories, Finished Goods
Get a 7-Day Free Trial 0.00 0.00 0.00 1.43 1.13

Belluscura Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Inventories, Finished Goods Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.00 1.43 0.00 1.13 1.21

Belluscura Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

What does a Inventories, Finished Goods of £1.21 Mil mean?
Belluscura (LSE:BELL) has a Inventories, Finished Goods of £1.21 Mil as of Jun. 2024. Finished goods are inventory items that are complete and ready to be sold. View historical data on Belluscura and its competitors.
Is Belluscura's Inventories, Finished Goods too high?
Belluscura's current Inventories, Finished Goods is £1.21 Mil.
How does Belluscura's Inventories, Finished Goods compare to ABT and BSX?
Belluscura's Inventories, Finished Goods of £1.21 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Finished Goods for a Medical Devices & Instruments company?
A good Inventories, Finished Goods depends on the Medical Devices & Instruments industry context. However, Inventories, Finished Goods should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Finished Goods mean?
A high Inventories, Finished Goods can signal that a stock is expensive relative to its fundamentals. Finished goods are inventory items that are complete and ready to be sold. View historical data on Belluscura and its competitors. Belluscura's current Inventories, Finished Goods is £1.21 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Belluscura stock overvalued right now?
Belluscura (LSE:BELL) has a current Inventories, Finished Goods of £1.21 Mil. The current Inventories, Finished Goods is £1.21 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Finished Goods calculated?
Inventories, Finished Goods is calculated from a company's financial statements. For Belluscura (LSE:BELL), the current Inventories, Finished Goods is £1.21 Mil as of Jun. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Belluscura Business Description

Address 15 Fetter Lane, Holborn, London, GBR, EC4A 1BW
Belluscura PLC is a medical device company. Its first product, the X-PLOR, is a lightweight FDA-cleared portable oxygen concentrator designed to replace larger, metal oxygen tanks and heavier portable oxygen concentrator devices. The company has only one operating segment being the sale of oxygen concentrators in the United States. The X-PLO2R weighs less than 1.5kg (3.25 lbs) and it is the first modular portable oxygen concentrator it will generate more oxygen by weight than any other FDA-cleared POC in its class. It either owns or exclusively licenses a total of 26 patents and applications relating to oxygen enrichment devices and treatments.